The effects of antihypertensive agents on endometrial thickness in asymptomatic, hypertensive, postmenopausal women
dc.contributor.author | Okman-Kilic, T | |
dc.contributor.author | Kucuk, M | |
dc.date.accessioned | 2024-06-12T11:00:24Z | |
dc.date.available | 2024-06-12T11:00:24Z | |
dc.date.issued | 2003 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objective: The aim of this study was to investigate, by using transvaginal ultrasonography, the possible effects on endometrial thickness of antihypertensive agents in asymptomatic postmenopausal women. Design: A prospective study in an outpatient menopause clinic of a university hospital. We included 288 postmenopausal women in this study, and we compared three groups of postmenopausal women as follows: (1) normotensive postmenopausal women, (2) hypertensive women treated with an antihypertensive drug (beta-blocker, non-beta-blocker, or beta-blocker plus non-p-blocker), and (3) untreated hypertensive women who had had hypertension for at least 1 year. Hypertensive women treated with a drug had been receiving treatment for 1 year. All women were interviewed and examined. Measurements of endometrial thickness were carried out by vaginal ultrasonography. Results: Sixty-two women (22%) were normotensive, and 226 (78%) of 288 women were hypertensive. Of the 226 women, 122 (54%) were receiving an antihypertensive drug. The mean (+/- SD) endometrial thicknesses in groups A, B, and C were 4.5 (+/- 1.3), 5.4 (+/- 1.5), and 6.4 (+/- 1.7) mm, respectively. Significant difference was obtained among the groups (P = 0.004). Conclusions: Our data indicate that the mean endometrial thickness is significantly greater in asymptomatic, hypertensive women receiving antihypertensive drugs than among untreated hypertensive and normotensive women. | en_US |
dc.identifier.doi | 10.1097/01.GME.0000051508.69832.BA | |
dc.identifier.endpage | 365 | en_US |
dc.identifier.issn | 1072-3714 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 12851520 | en_US |
dc.identifier.startpage | 362 | en_US |
dc.identifier.uri | https://doi.org/10.1097/01.GME.0000051508.69832.BA | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20812 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000184247300014 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Menopause-The Journal Of The North American Menopause Society | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Endometrial Thickness | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Menopause | en_US |
dc.subject | Antihypertensive Drugs | en_US |
dc.subject | Growth-Factors | en_US |
dc.subject | Cancer | en_US |
dc.title | The effects of antihypertensive agents on endometrial thickness in asymptomatic, hypertensive, postmenopausal women | en_US |
dc.type | Article | en_US |